An anti-parasitic drug available around the world stops SARS-CoV-2 coronavirus from replicating within a couple of days, according to findings from in vitro studies by Monash University, working with the Peter Doherty Institute of Infection and Immunity. Kylie Wagstaff, PhD, said the studies showed that ivermectin, started to become effective against SARS-CoV-2 in lab-grown cells within just a day. “We found that even a single dose cou ...

::::::::

An anti-parasitic drug available around the world stops SARS-CoV-2 coronavirus from replicating within a couple of days, according to findings from in vitro studies by Monash University, working with the Peter Doherty Institute of Infection and Immunity.

Kylie Wagstaff, PhD, said the studies showed that ivermectin, started to become effective against SARS-CoV-2 in lab-grown cells within just a day. “We found that even a single dose could essentially remove all viral RNA by 48 hours and that even at 24 hours there was a really significant reduction in it,” Wagstaff commented. The researchers’ report is available as a pre-proof paper in Antiviral Research, titled, “The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro.”

Ivermectin is approved by the FDA for treating a number of parasitic infections, and the drug has an established safety profile,

Authors Bio:

Josh Mitteldorf, de-platformed senior editor at OpEdNews, blogs on aging at http://JoshMitteldorf.ScienceBlog.com. Read how to stay young at http://AgingAdvice.org.

Educated to be an astrophysicist, he has branched out from there to mathematical modeling in a variety of areas, including evolutionary ecology and economics. He has taught mathematics, statistics, and physics at several universities. He is an avid amateur pianist, and father of two adopted Chinese girls, now grown. He travels to Beijing each year to work with a lab studying the biology of aging. His book on the subject is "Cracking the Aging Code", http://tinyurl.com/y7yovp87.